There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sol-Gel Technologies (SLGL – Research Report), Zentalis Pharmaceuticals (ZNTL – Research Report) and Oncology Institute, Inc. (TOI – Research Report) with bullish sentiments.
Sol-Gel Technologies (SLGL)
Raymond James analyst Elliot Wilbur maintained a Buy rating on Sol-Gel Technologies today and set a price target of $13.00. The company’s shares closed last Friday at $4.74, close to its 52-week low of $3.94.
According to TipRanks.com, Wilbur has 0 stars on 0-5 stars ranking scale with an average return of
Sol-Gel Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $13.50.
Zentalis Pharmaceuticals (ZNTL)
In a report released today, Matthew Harrison from Morgan Stanley maintained a Buy rating on Zentalis Pharmaceuticals, with a price target of $55.00. The company’s shares closed last Friday at $21.01, close to its 52-week low of $17.33.
According to TipRanks.com, Harrison is a 4-star analyst with an average return of
Currently, the analyst consensus on Zentalis Pharmaceuticals is a Strong Buy with an average price target of $45.50, which is a 126.3% upside from current levels. In a report issued on November 9, Stifel Nicolaus also maintained a Buy rating on the stock with a $58.00 price target.
Oncology Institute, Inc. (TOI)
Guggenheim analyst Sandy Draper maintained a Buy rating on Oncology Institute, Inc. today and set a price target of $6.00. The company’s shares closed last Friday at $2.38.
According to TipRanks.com, Draper is ranked #141 out of 8077 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Oncology Institute, Inc. with a $8.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SLGL:
- Analysts Are Bullish on These Financial Stocks: Fiserv (FISV), CION Investment Corp (CION)
- Analysts Have Conflicting Sentiments on These Utilities Companies: DTE Energy (DTE) and Edison International (EIX)
- Maxim Group Sticks to Its Buy Rating for Virpax Pharmaceuticals (VRPX)
- Zevia PBC (ZVIA) Receives a Hold from Morgan Stanley
- Morgan Stanley Keeps Their Hold Rating on Olink Holding (OLK)